PuSH - Publication Server of Helmholtz Zentrum München

15 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
Arnaldi, D.* et al.: Brain glucose metabolism heterogeneity in idiopathic REM sleep behavior disorder and in parkinson's disease. J. Parkinsons Dis. 9, 229-239 (2019)
Becker, A.* ; Faßbender, K.* ; Oertel, W.H. & Unger, M.M.*: A punch in the gut - Intestinal inflammation links environmental factors to neurodegeneration in Parkinson's disease. Parkinsonism Relat. Disord. 60, 43-45 (2019)
Kübler, D.* et al.: Widespread microglial activation in multiple system atrophy. Mov. Disord. 34, 564-568 (2019)
Chou, K.L.* et al.: The spectrum of "off" in Parkinson's disease: What have we learned over 40 years? Parkinsonism Relat. Disord. 51, 9-16 (2018)
Meles, S.K.* et al.: The metabolic pattern of idiopathic REM sleep behavior disorder reflects early-stage Parkinson’s disease. J. Nucl. Med. 59, 1437-1444 (2018)
Ouled Amar Bencheikh, B.* et al.: LRRK2 protective haplotype and full sequencing study in REM sleep behavior disorder. Parkinsonism Relat. Disord. 52, 98-101 (2018)
Doppler, K.* et al.: Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease. Acta Neuropathol. 133, 535-545 (2017)
Höllerhage, M.* et al.: Protective efficacy of phosphodiesterase-1 inhibition against alpha-synuclein toxicity revealed by compound screening in LUHMES cells. Sci. Rep. 7:11469 (2017)
Meles, S.K.* et al.: FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder. Mov. Disord. 32, 1482-1486 (2017)
Müller-Rebstein, S.* et al.: Pharmakotherapie des Morbus Parkinson. Aspekte der Arzneimitteltherapiesicherheit. Nervenarzt, 1-7 (2017)
Oertel, W.H.: Recent advances in treating Parkinson's disease. F1000 Res. 6:260 (2017)
Schormair, B. et al.: Identification of novel risk loci for restless legs syndrome: A meta-analysis of genome-wide association studies in individuals of European ancestry: A meta-analysis. Lancet Neurol. 16, 898–907 (2017)
Trenkwalder, C.* et al.: Ferric carboxymaltose in patients with restless legs syndrome and nonanemic iron deficiency: A randomized trial. Mov. Disord. 32, 1478-1482 (2017)
Schulte, E.C. et al.: Targeted resequencing and systematic in vivo functional testing identifies rare variants in MEIS1 as significant contributors to restless legs syndrome. Am. J. Hum. Genet. 95, 85-95 (2014)
Mengel, D.* et al.: Naturally occurring autoantibodies interfere with β-amyloid metabolism and improve cognition in a transgenic mouse model of Alzheimer's disease 24 h after single treatment. Transl. Psychiatry 3:e236 (2013)